S'abonner

Evaluation of Chest Radiographs of Children with Newly Diagnosed Acute Lymphoblastic Leukemia - 22/07/20

Doi : 10.1016/j.jpeds.2020.04.003 
Wesley T. Smith, DO 1, 2, 3, , Kenneth T. Shiao, BSE 1, , Elena Varotto, MD 1, Yinmei Zhou, MS 4, Mayuko Iijima, MD 1, Doralina L. Anghelescu, MD 5, Cheng Cheng, PhD 4, Sima Jeha, MD 1, 2, 6, Ching-Hon Pui, MD 1, 2, 7, Sue C. Kaste, DO 1, 8, 9, Hiroto Inaba, MD, PhD 1, 2,
1 Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 
2 Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 
3 Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX 
4 Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 
5 Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN 
6 Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN 
7 Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 
8 Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN 
9 Department of Radiology, University of Tennessee Health Science Center, Memphis, TN 

Reprint requests: Hiroto Inaba, MD, PhD, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 260, Memphis, TN 38105-2794.Department of OncologySt. Jude Children's Research Hospital262 Danny Thomas PlaceMail Stop 260MemphisTN38105-2794

Abstract

Objective

To evaluate the diagnostic yield of baseline chest radiographs (CXRs) of children with acute lymphoblastic leukemia (ALL).

Study design

We reviewed the CXR findings at diagnosis for 990 patients aged 1-18 years with ALL treated during the Total XV and XVI studies at St. Jude Children's Research Hospital and evaluated the associations of these findings with clinical characteristics and initial management.

Results

Common findings were peribronchial/perihilar thickening (n = 187 [19.0%]), pulmonary opacity/infiltrate (n = 159 [16.1%]), pleural effusion/thickening (n = 109 [11.1%]), mediastinal mass (n = 107 [10.9%]), and cardiomegaly (n = 68 [6.9%]). Portable CXRs provided results comparable with those obtained with 2-view films. Forty of 107 patients with a mediastinal mass (37.4%) had tracheal deviation/compression. Mediastinal mass, pleural effusion/thickening, and tracheal deviation/compression were more often associated with T-cell ALL than with B-cell ALL (P < .001 for all). Pulmonary opacity/infiltrate was associated with younger age (P = .003) and was more common in T-cell ALL than in B-cell ALL (P = .001). Peribronchial/perihilar thickening was associated with younger age (P < .001) and with positive central nervous system disease (P = .012). Patients with cardiomegaly were younger (P = .031), more often black than white (P = .007), and more often categorized as low risk than standard/high risk (P = .017). Patients with a mediastinal mass, pleural effusion/thickening, tracheal deviation/compression, or pulmonary opacity/infiltrate were more likely to receive less invasive sedation and more intensive care unit admissions and respiratory support (P ≤ .001 for all). Cardiomegaly was associated with intensive care unit admission (P = .008). No patients died of cardiorespiratory events during the initial 7 days of management.

Conclusions

The CXR can detect various intrathoracic lesions and is helpful in planning initial management.

Le texte complet de cet article est disponible en PDF.

Keywords : chest radiograph, acute lymphoblastic leukemia, children, diagnosis, management

Abbreviations : ALL, AP, B-ALL, CNS, CXR, ETP, ICU, MRD, St. Jude, T-ALL, WBC


Plan


 Supported by the National Institutes of Health (CA21765 [to all authors] and CA02394 [to K.S. and H.I.]) and ALSAC (to all authors). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest.
 Portions of this study were presented at the Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), May 3, 2018, Pittsburgh, Pennsylvania.


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 223

P. 120 - août 2020 Retour au numéro
Article précédent Article précédent
  • 50 Years Ago in The Journal of Pediatrics : Light Exposure to the Immature Eye
  • Jannicke H. Andresen, Ola Didrik Saugstad
| Article suivant Article suivant
  • Characteristics of Concussion in Elementary School-Aged Children: Implications for Clinical Management
  • Christina L. Master, Allison E. Curry, Melissa R. Pfeiffer, Kristina B. Metzger, Ronni S. Kessler, Juliet Haarbauer-Krupa, Lara DePadilla, Arlene Greenspan, Matthew J. Breiding, Kristy B. Arbogast

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.